Literature DB >> 1292077

Urinary excretion of citrate, glycosaminoglycans, magnesium and zinc in relation to age and sex in normal subjects and in patients who form calcium stones.

A Trinchieri1, A Mandressi, P Luongo, F Rovera, G Longo.   

Abstract

One hundred and ninety-seven healthy subjects and 104 patients with idiopathic calcium stone disease had their urinary excretion of citrate, glycosaminoglycans, magnesium, and zinc measured and the results correlated with sex and age. In normal subjects the daily excretion of citrate, magnesium, and zinc increased with age to a maximum during the fifth decade and remained relatively constant until the eighth decade when they decreased. The daily excretion of magnesium and zinc were higher in men than in women, which was attributed to the higher body weights of the men. The urinary excretion of citrate, magnesium, and zinc related to creatinine remained relatively constant with age in adult life; analyses of magnesium and zinc excretion rates divided by urine creatinine did not distinguish men from women. There was no significant difference between men and women for citrate excretion in 24 hour urine, but the citrate:creatinine ratio was significantly higher in women than men. The higher citrate excretion in women may explain the lower incidence of calcium stones in women. The highest glycosaminoglycan excretion rates were seen during the first two decades which is why children and teenagers are less prone to develop calcium stones in spite of high urinary calcium concentrations. Urinary citrate and magnesium excretion were lower, and glycosaminoglycan and zinc excretion were higher, in stone formers than in controls. It seems that a decreased excretion of citrate and magnesium together with an increased excretion of calcium, may contribute to the formation of calcium stones. The role of urinary glycosaminoglycans and zinc in the formation of calcium stones remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1292077     DOI: 10.3109/00365599209181230

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  8 in total

1.  Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios.

Authors:  Daniel Turudic; Danica Batinic; Anja Tea Golubic; Mila Lovric; Danko Milosevic
Journal:  Eur J Pediatr       Date:  2016-10-11       Impact factor: 3.183

2.  Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Benjamin W Turney; Paul N Appleby; John M Reynard; Jeremy G Noble; Timothy J Key; Naomi E Allen
Journal:  Eur J Epidemiol       Date:  2014-04-22       Impact factor: 8.082

3.  Dietary Zinc and Incident Calcium Kidney Stones in Adolescence.

Authors:  Gregory E Tasian; Michelle E Ross; Lihai Song; Robert W Grundmeier; James Massey; Michelle R Denburg; Lawrence Copelovitch; Steven Warner; Thomas Chi; David W Killilea; Marshall L Stoller; Susan L Furth
Journal:  J Urol       Date:  2016-11-23       Impact factor: 7.450

4.  Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers.

Authors:  Alberto Trinchieri; Renata Lizzano; Federica Marchesotti; Giampaolo Zanetti
Journal:  Urol Res       Date:  2006-01-20

Review 5.  The role of zinc in urinary stone disease.

Authors:  Armando Luis Negri
Journal:  Int Urol Nephrol       Date:  2018-01-17       Impact factor: 2.370

6.  Association of urinary citrate excretion, pH, and net gastrointestinal alkali absorption with diet, diuretic use, and blood glucose concentration.

Authors:  Majuran Perinpam; Erin B Ware; Jennifer A Smith; Stephen T Turner; Sharon L R Kardia; John C Lieske
Journal:  Physiol Rep       Date:  2017-10-16

7.  Effects of Sex on Intra-Individual Variance in Urinary Solutes in Stone-Formers Collected from a Single Clinical Laboratory.

Authors:  Guy M L Perry; Steven J Scheinman; John R Asplin
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

8.  Oral Zinc Sulfate as Adjuvant Treatment in Children With Nephrolithiasis: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Parsa Yousefichaijan; Ali Cyrus; Fatemeh Dorreh; Mohammad Rafeie; Mojtaba Sharafkhah; Faryar Frohar; Fatemeh Safi
Journal:  Iran J Pediatr       Date:  2015-12-23       Impact factor: 0.364

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.